Recommended
More Related Content
Viewers also liked
Viewers also liked (14)
Recently uploaded
Recently uploaded (20)
Epidermolysis bullosa pipeline review, h1 2015
- 1. Epidermolysis Bullosa - Pipeline Review, H1 2015 TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
- 2. Report Overview Scope - The report provides a snapshot of the global therapeutic landscape of Epidermolysis Bullosa - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Epidermolysis Bullosa and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Epidermolysis Bullosa products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Epidermolysis Bullosa pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Read More At : http://www.researchbeam.com/epidermolysis-bullosa-pipeline-review-h1-2015-market
- 3. Table of Content Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Epidermolysis Bullosa Overview 7 Therapeutics Development 8 Pipeline Products for Epidermolysis Bullosa - Overview 8 Pipeline Products for Epidermolysis Bullosa - Comparative Analysis 9 Epidermolysis Bullosa - Therapeutics under Development by Companies 10 Epidermolysis Bullosa - Therapeutics under Investigation by Universities/Institutes 11 Epidermolysis Bullosa - Pipeline Products Glance 12 Late Stage Products 12 Clinical Stage Products 13 Early Stage Products 14 Epidermolysis Bullosa - Products under Development by Companies 15 Epidermolysis Bullosa - Products under Investigation by Universities/Institutes 16 Epidermolysis Bullosa - Companies Involved in Therapeutics Development 17 Fibrocell Science, Inc. 17 GlaxoSmithKline plc 18 InMed Pharmaceuticals Inc. 19 RegeneRx Biopharmaceuticals, Inc. 20
- 4. Report Overview Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Epidermolysis Bullosa - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Epidermolysis Bullosa pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Enquire At : http://www.researchbeam.com/epidermolysis-bullosa-pipeline-review-h1-2015- market/enquire-about-report
- 5. FOR MORE DETAILS Visit us at : Stay With Us: http://www.researchbeam.com/epidermolysis-bullosa-pipeline-review-h1-2015-market 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com